Corneal transplantation is the most common form of grafting performed worldwide. Corneal endothelial cells (EC) form a monolayer in the posterior portion of the cornea and are essential for corneal transparency. EC loss during storage before transplantation is a principal reason for rendering donor tissue unsuitable for transplantation, and apoptosis has been shown to be the major contributor to EC loss during storage and after transplantation. Therefore, the potential use of anti-apoptotic gene therapy to promote both graft storage and graft survival is of major interest. The goal of this study was to transduce human donor corneas in vitro to enhance EC survival during storage conditions used in eye banking. We utilized a lentiviral vector to perform gene transfer of baculoviral p35 or mammalian Bcl-xL to corneal endothelium in different storage conditions utilizing a lentiviral vector. Our results show significantly enhanced survival and prolonged retention of physiological EC morphology in cells expressing either p35 or Bcl-xL. The clinical application of this technology could lead to a higher availability of donor tissue for transplantation, extend storage periods and reduce graft failure after transplantation.
INTRODUCTION
An estimated 29 million people worldwide suffer from blindness due to corneal disease, 1 80% of which could be prevented or treated with access to current therapeutic interventions. 2, 3 Presently, only 100 000 corneal transplantations (keratoplasties) are performed annually, with patients being waitlisted around the world due to short supply of donor corneas. 4 To obtain this quantity of donor corneas suitable for transplantation, nearly 220 000 donor corneas have to be processed each year by eye banks in the United States and European countries alone. 4 The major cause of donor tissue failure is loss of endothelial cells (EC), a cellular monolayer critical to maintaining corneal transparency and visual acuity. Owing to minimal to no cellular proliferation, EC loss is permanent. 5 During storage, the density of EC is a key criterion for the acceptance of a donor cornea for clinical use, as well as for evaluation of graft quality after transplantation. EC loss during storage is the principal reason for up to 30% of all discarded tissue by tissue banks. 4, 6 After transplantation, there is considerable and progressive EC loss; 7, 8 indeed, EC failure contributes to at least 25% of all failed grafts 15 years post-transplantation. 9 Previous studies have suggested that apoptosis is a key factor for EC loss during storage and for graft failure after transplantation. [10] [11] [12] [13] [14] [15] [16] [17] EC apoptosis appears to determine the appropriateness of a cornea for transplantation, suggesting that inhibition of apoptosis may prolong acceptable storage times. 10, 12 The cornea is a particularly suitable tissue for gene-therapy-based approaches for several reasons: Unlike some other solid tissues, it can be preserved for several weeks. This allows time for ex vivo genetic alteration before surgery, thereby minimizing systemic exposure to viral vectors. Moreover, the transparency of the cornea allows for direct visualization of the consequences of gene transfer. EC are readily accessible (as they are in direct contact with the storage medium) and hence amenable to gene transfer. 13, 16 Bcl-xL, a member of the Bcl-2 family of proteins, controls both mitochondria-initiated intrinsic apoptosis and receptor-initiated extrinsic cell death. 13, 18 The balance between pro-(for example, Bax) and anti-apoptotic components (for example, Bcl-2, Bcl-xL) is thought to function as a stabilizer controlling the cell's disposition to apoptosis. 19 p35 is an anti-apoptotic protein expressed by baculovirus, and was identified during genetic studies of this virus. 20, 21 It has a broad specificity for members of the caspase family, and can potently inhibit apoptosis induced by a wide range of stimuli. 22 Given the critical importance of EC viability in corneal transplantation and graft survival, we demonstrate the effects of anti-apoptotic gene therapy during corneal storage as a first step toward utilizing gene-therapy approaches to reduce donor tissue waste and posttransplantation graft failure.
RESULTS

Kinetics of IZsGreenW expression and apoptosis in EC
Experimental conditions were established by first assessing the kinetics of expression of the reporter gene IZsGreenW and the impact of transduction on cell viability. Our results indicate that the reporter protein could be detected in the cornea 48 h after transduction for 30 min (data not shown). Forty-eight hours after transduction for 1 h more than 80% of the cells expressed the reporter gene, and longer exposure to the virus only modestly increased this percentage (Figure 1) . DNA fragmentation as a sign of apoptosis was detected by deoxyuridine-5¢-triphosphate-digoxigenin (dUTP) nick-end labeling (TUNEL) and analyzed by confocal laser scanning microscopy.
The percentage of TUNEL-positive EC steadily increased with duration of transduction ( Figure 1 ). Consequently, we chose 1 h of transduction for all subsequent experiments, as it was a good balance between transduction efficiency and apoptosis.
Expression of anti-apoptotic proteins results in less EC apoptosis during prolonged storage and in a reduction of Caspase 3 We sought to evaluate the role of apoptosis in storage experiments relevant to eye banking. To assess whether anti-apoptotic gene transfer and subsequent protein expression result in increased viability during corneal preservation, we studied corneas stored under hypothermic conditions (4 1C, eye bank practice in North America and Asia) and under organ-culture conditions (37 1C, eye bank practice in Europe).
To induce death of corneal EC, corneas were stored in diluted medium. DNA fragmentation was detected using a TUNEL assay and confocal laser scanning microscopy. Results from these experiments demonstrate that expression of p35 or Bcl-xL leads to a significant decrease in apoptosis relative to parental vector controls (Figure 2) . Transduction of EC with Bcl-xL at a high titer resulted in a significant increase in TUNEL-positive EC (data not shown). Findings during storage at 4 1C ( Figure 2a) were confirmed in an eye bank setting at 37 1C (Figure 2b ). In addition, we could demonstrate that expression of anti-apoptotic proteins leads to a reduction of caspase 3 in EC (Figure 2c ).
Assessment of corneal EC density and morphology during hypothermic storage at 4 1C EC expressing anti-apoptotic proteins IZsGreenW-p35 and IZsGreenW-Bcl-xL retained a significantly higher EC count during long-term storage at 4 1C compared with untreated EC or EC expressing IzsGreenW only (parental vector) (Figure 3) . We expected the result given our finding that apoptosis is reduced in EC expressing both anti-apoptotic proteins, and considering that EC count is an independent measure of cell viability. As demonstrated in Figure 3a , protein expression (IZsGreenW) could still be detected after 11 weeks of storage using laser scanning microscopy. In addition, EC expressing p35 showed less apoptosis and intact cell morphology compared with Bcl-xL (more apoptosis) or the parental vector (cell lysis) (Figure 3b ). Studying cell density, untreated EC dropped below the cell count of 2000 EC mm À2 (critical threshold for eye banks to retain donor tissue) after 7 weeks, whereas EC expressing Bcl-xL achieved this point after 9 weeks, and EC expressing p35 retained counts above this threshold even after 11 weeks (Po0.01, Figure 3c ). EC enumerations during storage in highly diluted medium confirmed the protective effect of anti-apoptotic protein expression on EC survival (Figure 3d ). Of the two anti-apoptotic proteins tested, expression of the p35 protein was maximally protective against EC loss during storage.
Transduction with high titers lead to EC toxicity
We also sought to evaluate whether transduction with lenti-IZsGreenW-Bcl-xL using a significantly higher titer (1.2Â10 8 IU ml À1 ) resulted in increased EC protection compared with those transduced with lenti-IZsGreenW-Bcl-xL at a titer of 3Â10 5 IU ml À1 . Given that transduction with a very high titer of Bcl-xL increases the percentage of EC apoptosis, results from those experiments demonstrated significantly lower EC counts, and lower percentages of EC with physiological morphology, likely due to vector toxicity (Figure 3b , representative image).
EC expressing anti-apoptotic proteins retain physiological cell morphology Corneal EC morphology is a reliable indicator of cell viability, and may be altered under stress conditions and pre-apoptotic states well before cell death and a decrease in EC number. Typically, cells that are compromised lose the characteristic hexagonal cell shape. To assess the effect of these gene-therapy approaches on EC morphology, the percentage of EC retaining hexagonality was analyzed (Figures 3e  and f) . Expression of p35 or Bcl-xL (3Â10 5 IU ml À1 , each) preserved physiological morphology, whereas EC in the other groups developed pathological cell shapes. Interestingly, EC expressing p35 consistently retained higher percentages of hexagonal cell morphology compared with Bcl-xL.
Corneal EC count and morphology during organ storage at 37 1C As organ storage at 37 1C is widespread outside of the United States, especially in Europe, we assessed the protective effects of p35 and Bcl-xL during corneal donor-tissue storage at 37 1C. Results from these experiments were similar to those observed at 4 1C storage, in that we found that EC expressing p35 or Bcl-xL retained significantly higher EC counts (Figures 4a and b; Expression of anti-apoptotic proteins extends EC survival in an eye bank setting using donor pairs To test our hypothesis that EC survival can be promoted by antiapoptotic gene transfer in an eye bank environment, we compared both corneas (untreated versus treated) from the same donors in the next experiment. To test our hypothesis, standard operating procedures of ISO 9001/2000 (International Organization of Standardization)-certified organ-culture eye banks were adopted. 23 Intact corneas were clipped to Boehnke cornea holders and cultured in a standardized volume of medium using respective culture flasks under conditions according to the guidelines of the European Eye Bank Association. 24 Transduction of lenti-IZsGreenW was accomplished in one cornea of a donor pair, Expression of anti-apoptotic proteins by EC leads to a reduction of apoptosis during long-term storage. DNA fragmentation, a late sign of apoptosis, was detected by TUNEL (red) and laser scanning microscopy. Corneas were stored at 4 1C for 12 days (a; Optisol GS:phosphate-buffered saline (PBS)¼1:10) and at 37 1C for 9 days (b, Biochrome Culture Medium I:PBS¼1:10). Nuclei were stained blue with TO-PRO3, a dicycanine dye that binds to DNA. The cell borders were visualized using an antibody against the tight junction protein 1 (ZO-1, green). Inset images show TUNEL positivity in EC expressing a parental vector or Bcl-xL (six analyzed visual fields at each time point). Expression of anti-apoptotic proteins leads to a decrease in caspase 3 in EC, whereas apoptosis is induced using actinomycin D (c). The color reproduction of the figure is available on the html full text version of the manuscript.
whereas the other cornea was transduced with the gene of interest. Expression of both anti-apoptotic molecules p35 and Bcl-xL resulted in significantly increased EC counts during long-term storage (Po0.01, Figures 5a and b) . Assessment of cell morphology, however, showed that EC expressing Bcl-xL develop pathological cell morphology almost as rapidly as parental vector controls (Figure 5c ). little apoptosis IZsGreenW Figure 3 Assessment of corneal EC density and morphology during hypothermic storage at 4 1C. Untreated EC were compared with those expressing a parental vector (3Â10 5 IU ml À1 ), Bcl-xL (3Â10 5 IU ml À1 ) or p35 (3Â10 5 IU ml À1 ). EC densities and morphology of untreated EC and those expressing p35, Bcl-xL or a parental vector after storage for 11 weeks (a: Optisol GS:phosphate-buffered saline (PBS)¼1:1) or for 12 days (b: Optisol GS:PBS¼1:10) are demonstrated. Immunocytochemistry imaging in (a) and (b): TO-PRO3 (blue, nuclei), TUNEL (red, DNA fragmentation), IZsGreenW (a, green, co-expressed with the gene of interest) or ZO-1 (b, green, zonula occludens antibody). EC count was enumerated in EC stored in diluted Optisol GS, as indicated above. The point of interception of x and y axis in (c) and (d) corresponds to 2000 EC mm À2 , the minimum EC count used by eye banks to release donor corneas for transplantation. Corneal EC morphology was evaluated by enumeration of hexagonal EC (e). Optisol GS:PBS¼1:1, (f). Optisol GS:PBS¼1:10; the higher this ratio, the faster the decrease of physiological hexagonality and EC numbers; six analyzed visual fields at each time point). The dotted black line in c and e indicates a period of 14 days during which the use of Optisol GS, the most widespread culture medium for hypothermic corneal storage, is currently accepted. In contrast, expression of p35 resulted in the maintenance of physiological EC morphology (Po0.01, Figure 5d ).
Evaluation of EC viability during long-term storage
We also determined whether storage at 4 1C or at 371C is more favorable as to survival of EC within corneas subjected to gene therapy. To this end, we established how long it took for ECs to die (vital EC, chromatin condensation, single cell loss and massive cell loss) during long-term hypothermic and organ storage (Figure 6a ). Untreated EC and those expressing a parental vector (Figures 6b and c,  (37 1C) ) were compared with EC expressing p35 or Bcl-xL (Figures 6d  and e, (4 1C) (37 1C)) . Untreated EC or those expressing the parental vector showed massive EC loss after 8 weeks of storage at 4 1C (Figure 6b ). However, EC expressing p35 showed chromatin condensation after 8 weeks and single cell loss after 11 weeks (Figure 6d) . Similarly, during storage at 37 1C, untreated cells showed massive cell loss after 5 weeks (Figure 6c) . EC expressing p35, however, maintained vital appearance with no signs of chromatin condensation (Figure 6e ).
DISCUSSION
The results hereby presented demonstrate clear advantages to EC expressing anti-apoptotic proteins p35 or Bcl-xL during storage, both in terms of retention of cell viability and physiological cell morphology. Prolongation of corneal EC viability during storage by means of anti-apoptotic gene transfer is a novel finding that confirms our hypothesis that EC apoptosis is a pivotal process to loss of donortissue quality. Furthermore, we demonstrate that gene transfer of the pan-caspase inhibitor p35 prevents apoptosis in EC more effectively than Bcl-xL during both organ (37 1C) and hypothermic (4 1C) storage conditions. Application of this technology in eye banking could lead to an increase of donor corneas available for transplantation, and may lead to a decrease in graft failure, as EC deterioration is a common denominator for all forms of corneal graft failure in humans.
Previous studies have suggested protective effects of anti-apoptotic proteins in the rat, 25 mouse 13 and murine or human corneal EC. 13, 16, 26 Interestingly, such studies have not been performed in human corneas under adapted eye bank conditions, which would be crucial for application in grafted donor corneas. The findings of this study delineate the efficacy of EC protection by anti-apoptotic gene transfer under clinical conditions, both regarding the optimal type of gene and elucidating the potential impact of viral dose.
Gene transfer using a lentiviral vector is well known to lead to high gene expression in transduced cells. 25, 27 Application of lentiviral vectors results in retained cell viability after infection and a rapid onset of gene expression. 27, 28 Previous studies have shown that this vector can be used to successfully transduce rat, bovine, murine and human corneal EC. 13, 25, 27 As demonstrated in our experiments, lentiviralmediated gene expression resulted in high IZsGreenW expression 48 h post-infection after as few as 30 min. We investigated the effects of two virus titers on cell viability 29 by showing that transduction using a very high titer of Bcl-xL does not protect, but derogates, EC vitality due to increased apoptosis.
The functional relevance of EC expression of p35 or Bcl-xL is confirmed by the novel finding of prolonged cell viability and maintenance of physiological morphology under eye bank conditions. Currently, up to 30% of all donor corneas are considered unusable for corneal transplantation because of EC loss during organ preservation, 4, 6 and up to 16% during hypothermic storage. 11 Our data suggest that anti-apoptotic gene transfer could increase the yield of limited donor tissue by decreasing the rate at which eye banks reject donor tissues based on EC quality.
Our findings consistently show higher EC counts and a higher percentage of physiological morphology in EC expressing p35 compared with Bcl-xL. This difference might be explained by the different ways in which the two proteins interact within the cell-intrinsic suicide-signaling cascade. A key characteristic of the Bcl-2 protein family is that its members share sequence homology with four domains (BH1, 2, 3, 4) . The BH3 domain is essential for the promotion of the death function of pro-apoptotic molecules. 30 Interestingly, the anti-apoptotic proteins Bcl-xL or Bcl-2 merely inhibit pro-apoptotic molecules of the BH3-only subfamily (such as Bad, Bid or Bim). 31 Hence, multidomain pro-apoptotic molecules like Bax, Bak or Bok can still trigger the death program leading to apoptosis, whereas p35 directly inhibits a broad spectrum of caspases. Cleavage of the reactive site loop of p35 leads to translocation of its N-terminus into the active site of caspases resulting in irreversible caspase inhibition. 32, 33 Our data suggest that broad suppression of caspases seems to have a higher impact on preventing EC death than inhibition of select pro-apoptotic proteins of the Bcl-2 family.
Previous studies identify apoptosis, an act of cellular 'self-destruction' , as the main contributor to cell death during preservation. [10] [11] [12] 34 Depending on the approach of cell death evaluation, different percentages of EC undergoing apoptosis have been reported. 10, 12, 35 As apoptotic cells can be entirely removed by phagocytosis within an estimated time of 30 to 60 min, 36 detection is only possible within a specific timeframe and results in an underestimation of overall apoptosis. In this study, we demonstrate a significant decrease in apoptotic EC expressing anti-apoptotic genes p35 or Bcl-xL.
An important concern when applying anti-apoptotic strategies to EC is whether replication can be induced leading to local tumors in the targeted EC. Thanks to the very low proliferative capacity of the corneal endothelial monolayer, no reports of corneal endothelial tumors are described in the literature. EC are not even forming a bilayer, not even in in vitro experiments. Therefore, the chance to induce local tumors is minimal to null. Secondly, approaches targeting EC have been of two types: (a) to induce proliferation of EC; and (b) to suppress EC death, which is the strategy employed herein. Whereas by promoting proliferation there could be a viable concern of inducing certain pathologies, by suppression of EC death, tumor induction is not possible. This is confirmed by the 'proof of principle' experiment in the mouse model transplanting corneas with EC treated with the same viral vector construct used in this study (lenti-IZsGrBcl-xL). The data showed that corneal grafts with EC expressing Bcl-xL resulted in a significantly enhanced graft survival compared with controls without signs of pathological proliferation, of EC or other cells (routine follow-up time in this model is 8 weeks). 13 However, longer follow-up periods in this model might be necessary to further evaluate the safety of this approach.
Another important question is whether or how many viral vector particles remain on the donor tissue after washing the endothelium with phosphate-buffered saline at the end of the transduction period. Residual viral vector could lead to transduction of other cell types in the anatomical vicinity of the corneal endothelium, raising safety concerns of induction of tumorigenic processes. However, the neighboring cells to the EC in the cornea are either stromal keratocytes (with a low proliferative capacity and with no predilection for tumorogenesis) or epithelial cells (which are entirely replaced by epithelial cells of the host soon after surgery). To study potential hazards, further studies are required. In our study, we were able to detect gene expression without appreciable diminution up to 11 weeks after transduction at readily detectable levels. These data are confirmed by previous work of this group in the mouse transplantation model 13 (expression after 8 weeks was readily detectable).
Given the biology of the EC as a monolayer, it is conceivable that this approach could be translated to other cell sheet transplantations. Examples could include cultured mesenchymal stem cells to enhance bone formation 37 or transplantation of tissue-engineered corneal epithelial sheets. 38 Given the risk that uncontrollable cell division of cells expressing anti-apoptotic genes could result in tumor formation, the transfer of this methodology to cell types with a high proliferative capacity should be exercised with caution.
In summary, these findings provide new insights on the roles of both the mammalian anti-apoptotic protein Bcl-xL and the baculoviral protein p35 in prolonging survival of EC during preservation. To our knowledge, we have shown for the first time that cell survival of human EC can be enhanced during preservation by means of gene therapy. Moreover, application of anti-apoptotic gene transfer may be further synergized with the recent advancements in the transplantation of the corneal endothelial monolayer, which is currently being globally implemented in corneal transplantation clinics. 39 In addition, application of anti-apoptotic gene therapy in eye banks before transplantation could lead to an increase of available donor corneas, which could impact the availability of donor tissue for millions of people suffering from corneal blindness.
MATERIALS AND METHODS
Lentivirus expression system
The complementary DNA of mammalian anti-apoptotic protein Bcl-xL or the baculoviral anti-apoptotic molecule p35 was subcloned into the lentiviral vector pHAGE-CMV-MCS-IZsGreenW by the Harvard Gene Therapy Initiative. Both genes were cloned into the multiple cloning site that is followed by an internal ribosomal entry site and the coding sequence for the green fluorescent protein IZsGreenW, which is derived from a reef coral. The internal ribosomal entry site sequence allows for two open reading frames on one mRNA. The vectors lenti-IZsGreenW (parental vector), lenti-IZsGreenWBcl-xL and lenti-IZsGreenW-p35 constructs are replication incompetent. 40 
Gene transfer in cultured corneas
Gene transfer in human donor corneas was carried out either on intact corneas or on single corneas cut into several pieces: To exclude donor-related variation, experiments were carried out by cutting single corneas into five pieces. Each piece served as an untreated control, and was transduced with lenti-CMV-MCS-IZsGreenW (parental vector, 3Â10 5 IU ml À1 ), lenti-CMV-IZsGreenWbclxL (3Â10 5 IU ml À1 ) and lenti-CMV-IZsGreenW-p35 (3Â10 5 IU ml À1 ). To detect the relevance of viral vector titer on EC protection against cell loss and apoptosis, the fifth corneal piece was transduced with lenti-CMV-IZsGreenWBcl-xL using a titer of 1.2Â10 8 IU ml À1 . In addition, to simulate eye bank conditions, experiments with intact pairs of cornea from the same donor were performed. One cornea was transduced with the parental vector lenti-CMV-MCS-IZsGreenW, whereas the other cornea was transduced with the gene of interest (3Â10 5 IU ml À1 , each).
Intact corneas or corneal pieces were incubated with the gene of interest or the parental vector for 1 h at 37 1C in Biochrome Cornea Culture Medium I containing 8 mg ml À1 polybrene. To remove excess virus, corneas were washed with sterile phosphate-buffered saline before storage in the respective culture medium.
Corneal storage and induction of corneal EC loss
The aspects of corneal preservation were adapted from standard operating procedures and good laboratory practices published by the Eye Bank Association of America (EBAA) and the European Eye Bank Association (EEBA). 24, 41, 42 Corneas were obtained from eye banks and stored under organ-culture (37 1C, Biochrome Cornea Medium I, Berlin, Germany) or under hypothermic (4 1C, Optisol GS, Bausch & Lomb, Rochester, NY, USA) conditions. Both storage media are internationally well established in eye banks and represent current standards of practice conditions for corneal transplantation. To promote cell death, the respective storage media were diluted with calcium-free phosphate-buffered saline at a ratio of 1:1, 1:4 or 1:10 (organ culture) or 1:1 or 1:10 (hypothermic storage). Depending on the dilution, corneas were stored between 9 days and 11 weeks, and were evaluated every 72 h or every week (Table 1, n¼22).
Detection of transgene expression, measurement of apoptosis and caspase 3
Transgene expression in cultured corneas was analyzed 0 (control), 1, 6 and 24 h after transduction (n¼2, single corneas cut into equal pieces). In addition, apoptosis was detected using a terminal deoxyribonucleotidyl transferase (TdT)-mediated TUNEL assay (In Situ Cell Death Detection Kit, Roche Diagnostics GmbH, Mannheim, Germany), according to the manufacturer's instructions. Vital nuclei were visualized using To-Pro 3 iodide (Invitrogen, Eugene, OR, USA). Cell borders were visualized using rabbit anti-ZO-1 (N term) (Invitrogen, Carlsbad, CA, USA). Corneas were washed and mounted with Vectashield's medium for fluorescence (Vector Laboratories, Burlingame, CA, USA). IZsGreenW expression, TUNEL positivity was detected by a Leica TSC-SP2 confocal laser scanning microscope (Â40) (Leica, Wetzlar, Germany). Caspase 3 in human EC was detected by flow cytometry after induction of apoptosis with 5 ng ml À1 Actinomycin D (for 24 h) using the antibody cleaved Caspase 3 (Asp175) (Cell Signaling, Beverly, MA, USA).
Detection of corneal EC loss and measurement of EC morphology
EC were visualized using the inverted research microscope Nikon Eclipse TE2000-S (Nikon Instruments Inc., Melville, NY, USA) (Â10, bright-field mode), a microscope also used in eye banks. Enumeration of EC and analysis of hexagonality were performed using eye bank software allowing automated cell counts and simultaneous measurement of cell shape variation from hexagonal morphology (Endothelium Analysis Tool, Rhine-Tec GmbH, Krefeld, Germany). To obtain representative data, three visual fields were examined and analyzed in each corneal piece during experiments using single corneas cut into equal pieces. In intact corneas, a total of eight visual fields were examined and analyzed (two in the center, three in the mid-periphery, three in the periphery of the cornea). Evaluation of stored corneas was performed every 3 days (1:10 dilutions) or weekly (1:4, 1:1 dilutions). In addition to the parameters above, certain phases of EC loss could be determined by comparison of the microscopy images to reference images.
Computations and statistical analysis
To verify the significance, the Student's t-test and the Mann-Whitney test were applied (P-values o0.05 were considered significant, P-values o0.01 as highly significant). Where appropriate, we initially used analysis of variance to test the global hypothesis of no group-mean differences in the three groups (control, p35, Bcl-xL). Regarding statistical analyses, error bars displayed in the figures were calculated from ± s.d. 
